In this study, we screened the potential unique immunophenotype of APL by selectively comparing homogenous AML patients whose leukemia cells did not express CD34 and HLA-DR, but expressed CD117 (Table 1), and who had no t(15;17) translocation or abnormal RARα fusion. This evidence concerns the gene RARA and acute promyelocytic leukemia.